El impacto de los medicamentos modificadores de la enfermedad en el perfil lipídico de los pacientes con enfermedad cardíaca isquémica
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La terapia combinada con medicamentos modificadores de la enfermedad reduce significativamente los parámetros lipídicos en pacientes con enfermedad isquémica del corazón (EII). Este enfoque ofrece una estrategia valiosa para controlar los factores de riesgo de EII como el infarto de miocardio (IM) y el accidente cerebrovascular.
Área De La Ciencia
- Cardiología
- Farmacología
Sus Antecedentes
- Las enfermedades isquémicas del corazón (IHD) implican el estrechamiento de las arterias coronarias, aumentando los riesgos de infarto de miocardio (IM) y accidente cerebrovascular.
- La alta morbilidad y mortalidad asociadas con la EII plantean importantes desafíos para la atención sanitaria.
Objetivo Del Estudio
- Evaluar el papel de los medicamentos modificadores de la enfermedad (DMM) en el control de los factores de riesgo de EII.
- Los DMM específicos investigados incluyen estatinas, inhibidores de SGLT2 y inhibidores de PCSK9.
Principales Métodos
- Un ensayo controlado aleatorizado en el que participaron 500 pacientes en cuatro grupos de tratamiento: estatinas, inhibidores de SGLT2, inhibidores de PCSK9 y terapia combinada.
- Los parámetros de lípidos séricos se evaluaron al inicio y 12 meses después del tratamiento.
Principales Resultados
- Todos los grupos de tratamiento mostraron una reducción en los parámetros lipídicos después de 12 meses.
- La terapia combinada produjo la reducción de lípidos más significativa (-74±10 mg/ dl, p< 0, 05).
- La edad y el sexo mostraron una modulación menor de la respuesta al tratamiento.
Conclusiones
- La terapia combinada con DMM es una estrategia prometedora para controlar los parámetros lipídicos en pacientes con EII.
- Este enfoque puede reducir los riesgos de accidente cerebrovascular e infarto de miocardio, ofreciendo un papel terapéutico adicional en el manejo de enfermedades cardiovasculares.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...